Three European biomedical research infrastructures — EATRIS-ERIC (focused on translational medicine), BBMRI-ERIC (focused on biobanking) and ELIXIR (focused on data sharing) — are paving the way to developing and sharing best practices for biomarker validation.
BiomarkerBay offers clinical validation of your biomarker assays in high quality samples from a variety of general population and patient cohorts.
The Research and Valorization office of University of Groningen has interviewed Dr. Ymke van der Geld, director Business Development and Dr. Martin Smit, member of the Board, on the unique selling points of BiomarkerBay.
